600 patients66,869 observations120 daysLIVE

Patient P-01794

Synthetic patientNBL-101 · Day 116 · 65–74 · F · baseline S09Open companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
54%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S09
  2. Day 77 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 77.

Primary contributors, last 14 days
  • Nutritional resilience+5
  • GI instability-4
  • Inflammatory activity-3
  • Toxicity-3
  • Treatment adherence+2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    65%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 80
      • MicrobiomeButyrate capacity 29/100
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Mucosal barrier integrity 50
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 58 and rising
    • Inflammatory signalling 45
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 62
    • Autonomic recovery 25
      • WearableResting HR 86 bpm
    • Drug metabolism and exposure 20
      • BloodToxicity index 51
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3 · butyrate capacity 29/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    41 ms
    Sleep
    7.1 h
    Steps
    6,113
    Resting HR
    86 bpm
    Daily log: GI score 58, nutritional resilience 38, adherence 72.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0147053%S1655
    P-0169752%S0955
    P-0160051%S0651
    P-0170851%S07CR-01improved59
    P-0171550%S0556
    P-0131048%S0157
    P-0146948%S1958
    P-0152147%S1453
    P-0176947%S2060
    P-0162344%S1652
    P-0177844%S0859
    P-0179544%S0661